Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    mental health

    Sedative, hypnotic or anxiolytic use disorder

    Also known as: Sedative use disorder, Hypnotic use disorder, Anxiolytic use disorder, Benzodiazepine use disorder, Z-drug use disorder

    Sedative, hypnotic or anxiolytic use disorder involves impaired control over use and continued use despite harm; physiological dependence alone does not establish the diagnosis. Clinical assessment should address intoxication, withdrawal risk, and co-occurring substance use, alongside mental health and sleep disorders. For Z-drugs, current research supports comprehensive assessment, gradual clinician-managed tapering, and cognitive behavioural therapy for insomnia; these recommendations should not automatically be generalised to all sedatives. Pharmacist involvement can support medication review and coordinated care. Chinese medicine may be considered only as an adjunct for managing associated distress or sleep complaints after medical stabilisation. The evidence cited here does not evaluate acupuncture or Chinese herbal treatment for this disorder, ensuring withdrawal safety, or preventing relapse.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Ensure secure storage of all medications and maintain a comprehensive record of all prescribed, over-the-counter, and herbal preparations for clinical review.
    • •Abstain from alcohol and non-prescribed sedatives; ensure any changes to opioid or sedative regimens are managed strictly by the prescribing clinician.
    • •Maintain a consistent rising time and utilise a sleep diary to document daytime functioning and symptoms without altering dosage independently.
    • •Establish a supportive contact network and secure safe transport; refrain from operating heavy machinery or driving if experiencing somnolence, cognitive impairment, or withdrawal symptoms.

    Cautions & Contraindications

    See sources
    • •Do not recommend abrupt cessation or an independent taper. Dependence severity, mental state and sleep or psychiatric comorbidities require assessment; the supplied Z-drug guideline recommends gradual tapering under clinical management.[]
    • •Do not initiate herbs without complete medication reconciliation and prescriber or pharmacist coordination, particularly with multiple psychotropics. The supplied pharmacy study supports coordinated medication review but does not establish the safety of any herb–drug combination.[]
    • •Defer elective needling during intoxication, suspected acute withdrawal, impaired consent or acute psychiatric instability and arrange medical assessment. This procedural precaution is not tested in the supplied abstracts; [2] supports assessment before discontinuation.[]

    When to reassess or seek care again

    See sources

    Medical monitoring frequency must be set by the prescriber according to withdrawal risk, with prompt contact after new symptoms or dose changes. For stable adjunctive care, review within 1–2 weeks using a sleep diary, daytime functioning, anxiety rating, adverse effects and adherence to the agreed medical plan. Record substance use non-judgementally without directing dose changes. Seek same-day medical review for worsening tremor, agitation, palpitations or escalating use; emergency signs require immediate escalation. If no meaningful supportive benefit is evident by 2–4 weeks, reconsider or stop adjunctive treatment and coordinate further addiction, mental health or sleep-service care.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Journal of general internal medicine · 2025
    2. Arquivos de neuro-psiquiatria · 2025
    3. BMC psychiatry · 2018

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.